BNP Paribas Financial Markets’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-7,127
| Closed | -$41.7K | – | 4661 |
|
|
2019
Q1 | $41.7K | Buy |
7,127
+4,883
| +218% | +$16.6K | ﹤0.01% | 3607 |
|
|
2018
Q4 | $2.92K | Buy |
2,244
+1,654
| +280% | +$2.87K | ﹤0.01% | 3730 |
|
|
2018
Q3 | $2.04K | Sell |
590
-3
| -0.5% | -$11 | ﹤0.01% | 4254 |
|
|
2018
Q2 | $2.7K | Sell |
593
-5,520
| -90% | -$22K | ﹤0.01% | 4220 |
|
|
2018
Q1 | $20.2K | Sell |
6,113
-2,714
| -31% | -$9.61K | ﹤0.01% | 3922 |
|
|
2017
Q4 | $34.4K | Buy |
8,827
+7,350
| +498% | +$40K | ﹤0.01% | 3832 |
|
|
2017
Q3 | $15.3K | Sell |
1,477
-98
| -6% | -$964 | ﹤0.01% | 3731 |
|
|
2017
Q2 | $15.4K | Buy |
1,575
+1,286
| +445% | +$9.02K | ﹤0.01% | 3798 |
|
|
2017
Q1 | $1.97K | Sell |
289
-523
| -64% | -$3.02K | ﹤0.01% | 3545 |
|
|
2016
Q4 | $4.47K | Buy |
812
+58
| +8% | +$410 | ﹤0.01% | 3748 |
|
|
2016
Q3 | $5.71K | Buy |
754
+318
| +73% | +$2.33K | ﹤0.01% | 3361 |
|
|
2016
Q2 | $3.56K | Buy |
436
+384
| +738% | +$4.79K | ﹤0.01% | 3381 |
|
|
2016
Q1 | $676 | Sell |
52
-2,158
| -98% | -$24.9K | ﹤0.01% | 2540 |
|
|
2015
Q4 | $44.4K | Sell |
2,210
-337
| -13% | -$5.81K | ﹤0.01% | 2891 |
|
|
2015
Q3 | $31.1K | Buy |
2,547
+1,606
| +171% | +$30.1K | ﹤0.01% | 3150 |
|
|
2015
Q2 | $19.4K | Buy |
941
+799
| +563% | +$18.9K | ﹤0.01% | 3066 |
|
|
2015
Q1 | $3K | Buy |
+142
| New | +$3.71K | ﹤0.01% | 3384 |
|
BNP Paribas Financial Markets's IMDZ Position: Q2 2019 in Review
BNP Paribas Financial Markets sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 7,127 shares — an estimated $41.7K sold.
BNP Paribas Financial Markets first reported a position in IMDZ in Q1 2015 and held it in 17 quarters. The position peaked at $44.4K in Q4 2015. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- BNP Paribas Financial Markets reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 7,127 Immune Design Corp. shares in Q2 2019, an estimated $41.7K.
- BNP Paribas Financial Markets first reported a position in Immune Design Corp. in Q1 2015 and held it in 17 quarters.
- BNP Paribas Financial Markets's Immune Design Corp. position peaked at $44.4K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.